登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
C25H30N3Cl
化学文摘社编号:
分子量:
407.98
UNSPSC Code:
12171500
NACRES:
NA.47
PubChem Substance ID:
EC Number:
208-953-6
MDL number:
Beilstein/REAXYS Number:
3580948
产品名称
结晶紫, certified by the BSC
SMILES string
[Cl-].CN(C)c1ccc(cc1)\C(c2ccc(cc2)N(C)C)=C3/C=C\C(C=C3)=[N+](/C)C
InChI key
ZXJXZNDDNMQXFV-UHFFFAOYSA-M
InChI
1S/C25H30N3.ClH/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6;/h7-18H,1-6H3;1H/q+1;/p-1
agency
certified by the BSC
form
powder
composition
Dye content, ≥90%
technique(s)
microbe id | staining: suitable
color
green to very dark green
pH
2.5 — 3.5 (20 °C)
mp
205 °C (dec.) (lit.)
solubility
H2O: 1 mg/mL
density
1.19 g/cm3 at 20 °C
antibiotic activity spectrum
fungi
application(s)
diagnostic assay manufacturing
hematology
histology
mode of action
cell membrane | interferes, enzyme | inhibits
storage temp.
room temp
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
经认证可用于细菌的革兰氏染色,用于染色体的碘染色的 Flemming 三重染色,用于染色质和核仁的 Lieb′s淀粉样染色和牛顿′ 结晶紫碘染色技术。
结晶紫被用作革兰氏染色的活性成分、原始染色,用于革兰氏阴性细菌与革兰氏阳性细菌的鉴定。
它已被用于检测细胞活力。它还被用于细胞染色,以研究细胞迁移和侵袭。
它已被用于检测细胞活力。它还被用于细胞染色,以研究细胞迁移和侵袭。
Biochem/physiol Actions
结晶紫可用于琼脂糖凝胶中可视化 DNA。这种染料仅在 DNA 浓度高的情况下使用。结晶紫也用于革兰染色技术中的细菌染色。它还用于植物染色体的染色。晶体紫还有助于细胞活力的比色测定。
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Eye Dam. 1
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet.
Ishiyama M, et al.
Biological & Pharmaceutical Bulletin, 19, 1518-1518 (1996)
Sharma A
Plant Chromosomes (1999)
Lipocalin 2 induces the epithelial-mesenchymal transition in stressed endometrial epithelial cells: possible correlation with endometriosis development in a mouse model.
Liao CJ, et al.
Reproduction (Cambridge, England), 147, 179-179 (2013)
Carson S and Robertson D
Manipulation and Expression of Recombinant DNA (2005)
Ping Jin et al.
Cell death & disease, 10(8), 615-615 (2019-08-15)
Colorectal cancer (CRC) is one of the most frequently diagnosed cancers worldwide. Development of novel chemotherapeutics is still required to enable successful treatment and improve survival for CRC patients. Here, we found that osimertinib (OSI) exhibits potent anti-CRC effects by
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持


